Virenix Overview

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Virenix General Information

Description

Developer of antiviral drugs for diseases designed to improve treatments for viral diseases. The company offers research support for antiviral drug discovery, access to a catalog of viral proteins, software for crystallography and protein expression, and services for screening viral proteins and viruses, enabling clients to accelerate drug discovery processes, access specialized resources for research, and develop treatments efficiently.

Contact Information

Website
www.virenix.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • South Africa
Primary Industry
Other Commercial Services
Vertical(s)
Corporate Office
  • South Africa

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Virenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 30-Dec-2024 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view Virenix’s complete valuation and funding history, request access »

Virenix FAQs

  • Where is Virenix headquartered?

    Virenix is headquartered in South Africa.

  • What industry is Virenix in?

    Virenix’s primary industry is Other Commercial Services.

  • Is Virenix a private or public company?

    Virenix is a Private company.

  • What is Virenix’s current revenue?

    The current revenue for Virenix is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process